Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Allakos Inc (ALLK)

Allakos Inc (ALLK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 29,743
  • Shares Outstanding, K 90,377
  • Annual Sales, $ 0 K
  • Annual Income, $ -115,820 K
  • EBIT $ -76 M
  • EBITDA $ -72 M
  • 60-Month Beta 0.15
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.54
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.51
  • Most Recent Earnings $-0.29 on 05/07/25
  • Next Earnings Date 08/06/25
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate -0.24
  • Number of Estimates 1
  • High Estimate -0.24
  • Low Estimate -0.24
  • Prior Year -0.30
  • Growth Rate Est. (year over year) +20.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3191 +3.13%
on 04/15/25
0.3299 -0.24%
on 05/12/25
+0.0086 (+2.68%)
since 04/14/25
3-Month
0.2157 +52.57%
on 04/01/25
0.3299 -0.24%
on 05/12/25
+0.0164 (+5.24%)
since 02/14/25
52-Week
0.2157 +52.57%
on 04/01/25
1.5550 -78.84%
on 11/11/24
-0.8609 (-72.34%)
since 05/14/24

Most Recent Stories

More News
Allakos Inc. Enters into Agreement to Be Acquired by Concentra Biosciences, LLC for $0.33 in Cash per Share

ALLK : 0.3291 (-0.06%)
Allakos Provides Business Update and Reports Fourth Quarter 2024 Financial Results

ALLK : 0.3291 (-0.06%)
Allakos Stock Craters To Record Low On Lead Drug Setback: Retail Hopes Fade

The disappointing results prompted Allakos to terminate AK006-related programs across all functions and implement a 75% workforce reduction.

ALLK : 0.3291 (-0.06%)
Allakos Announces Topline Results from its Phase 1 Trial of AK006 in Patients with Chronic Spontaneous Urticaria and Announces Restructuring

ALLK : 0.3291 (-0.06%)
Allakos Provides Business Update and Reports Third Quarter 2024 Financial Results

ALLK : 0.3291 (-0.06%)
Allakos Announces Phase 1 Trial Results of Subcutaneous AK006 in Healthy Volunteers

ALLK : 0.3291 (-0.06%)
Why Shares of Allakos Are Up Wednesday

The stock is bouncing back from a recent 52-week low.

ALLK : 0.3291 (-0.06%)
Why Allakos Stock Skyrocketed Nearly 9% Higher Today

The company is poised to report a critical set of clinical data in the coming months.

ALLK : 0.3291 (-0.06%)
Why Allakos Stock Was Heating Up Today

A notable analyst upgrade had investors piling into this clinical-stage biotech stock today.

ALLK : 0.3291 (-0.06%)
PIPR : 346.90 (+1.05%)
Why Allakos Stock Is on Fire Today

Investors appear to be getting into position ahead of a major upcoming catalyst.

ALLK : 0.3291 (-0.06%)

Business Summary

Allakos Inc. is a clinical stage bio-technology company. It discovers and develops therapeutic antibodies for the treatment of allergic, inflammatory and proliferative diseases. Allakos Inc. is based in CA, United States.

See More

Key Turning Points

3rd Resistance Point 0.3308
2nd Resistance Point 0.3302
1st Resistance Point 0.3296
Last Price 0.3291
1st Support Level 0.3284
2nd Support Level 0.3278
3rd Support Level 0.3272

See More

52-Week High 1.5550
Fibonacci 61.8% 1.0434
Fibonacci 50% 0.8853
Fibonacci 38.2% 0.7273
Last Price 0.3291
52-Week Low 0.2157

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar